|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Cost of revenue |
|
$ |
1,835 |
|
|
$ |
679 |
|
|
$ |
5,339 |
|
|
$ |
6,758 |
|
Sales and marketing |
|
|
15,483 |
|
|
|
11,178 |
|
|
|
38,351 |
|
|
|
57,285 |
|
Research and development |
|
|
17,758 |
|
|
|
15,064 |
|
|
|
43,910 |
|
|
|
69,627 |
|
General and administrative |
|
|
9,701 |
|
|
|
11,262 |
|
|
|
28,281 |
|
|
|
52,259 |
|
Total stock-based compensation expense |
|
$ |
44,777 |
|
|
$ |
38,183 |
|
|
$ |
115,881 |
|
|
$ |
185,929 |
|
|
Procore Announces Third Quarter 2022 Financial Results
(1) Includes stock-based compensation expense as follows:
|
|
||||||
|
|
|||||||
|
|||||||
